- Report
- January 2024
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- December 2023
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- February 2024
- 115 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- July 2023
- 220 Pages
Global
€4435EUR$4,595USD£3,804GBP
- Report
- July 2023
- 179 Pages
Global
From €4343EUR$4,500USD£3,726GBP
- Report
- October 2022
- 165 Pages
Global
From €2114EUR$2,190USD£1,813GBP
- Report
- June 2022
- 81 Pages
Middle East, Africa
From €1448EUR$1,500USD£1,242GBP
- Report
- November 2023
- 78 Pages
From €2847EUR$2,950USD£2,442GBP
- Report
- January 2020
- 210 Pages
Global
From €5183EUR$5,370USD£4,446GBP
The Ambulatory Infusion Center market is a segment of the Infusions and Injectables market that provides outpatient services for the administration of medications. These centers provide a variety of services, including intravenous (IV) therapy, chemotherapy, and other treatments. They are typically staffed by nurses and other healthcare professionals who specialize in administering medications. Ambulatory Infusion Centers are often located in hospitals, medical offices, or other healthcare facilities.
The Ambulatory Infusion Center market is growing due to the increasing demand for outpatient services and the need for specialized care. This market is expected to continue to grow as more patients seek out these services.
Some companies in the Ambulatory Infusion Center market include Fresenius Medical Care, CVS Health, and Walgreens. Other companies include Apria Healthcare, BioScrip, and Option Care Health. Show Less Read more
